{
  "ticker": "SMMT",
  "company_name": "Summit Therapeutics Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05382442",
      "title": "A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Metastatic Colorectal Cancer",
      "start_date": "2022-06-27",
      "completion_date": "2028-08-12",
      "enrollment": 0,
      "sponsor": "Akeso"
    },
    {
      "nct_id": "NCT05899608",
      "title": "Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Non-Small Cell Lung Cancer",
      "start_date": "2023-10-26",
      "completion_date": "2029-12-31",
      "enrollment": 0,
      "sponsor": "Summit Therapeutics"
    },
    {
      "nct_id": "NCT04292301",
      "title": "MRI Assessing Clinical Usability of STrategically Acquired Gradient Echo on Human Participants",
      "status": "COMPLETED",
      "phase": "NA",
      "condition": "MRI",
      "start_date": "2020-06-30",
      "completion_date": "2021-01-07",
      "enrollment": 0,
      "sponsor": "SpinTech, Inc."
    },
    {
      "nct_id": "NCT06064162",
      "title": "Ketamine for MS Fatigue",
      "status": "COMPLETED",
      "phase": "EARLY_PHASE1",
      "condition": "Multiple Sclerosis",
      "start_date": "2023-12-05",
      "completion_date": "2025-05-05",
      "enrollment": 0,
      "sponsor": "Alta Bates Summit Medical Center"
    },
    {
      "nct_id": "NCT02784002",
      "title": "A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Clostridium Difficile Infection",
      "start_date": "2014-12",
      "completion_date": "2016-08",
      "enrollment": 0,
      "sponsor": "Summit Therapeutics"
    },
    {
      "nct_id": "NCT06429436",
      "title": "Vending Machine Naloxone Distribution for Your Community (VENDY)",
      "status": "RECRUITING",
      "phase": "PHASE4",
      "condition": "Harm Reduction, Naloxone, Opioid Overdose",
      "start_date": "2024-06-01",
      "completion_date": "2026-06-30",
      "enrollment": 0,
      "sponsor": "University of Colorado, Denver"
    },
    {
      "nct_id": "NCT06767514",
      "title": "Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Non-Small Cell Lung Cancer",
      "start_date": "2025-02-27",
      "completion_date": "2029-06",
      "enrollment": 0,
      "sponsor": "Summit Therapeutics"
    },
    {
      "nct_id": "NCT06840834",
      "title": "Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Pleural Mesotheliomas",
      "start_date": "2025-06-30",
      "completion_date": "2028-03-31",
      "enrollment": 0,
      "sponsor": "Intergroupe Francophone de Cancerologie Thoracique"
    },
    {
      "nct_id": "NCT07359456",
      "title": "Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE2",
      "condition": "Metastatic Colorectal Cancer",
      "start_date": "2026-03",
      "completion_date": "2032-03",
      "enrollment": 0,
      "sponsor": "UNICANCER"
    },
    {
      "nct_id": "NCT03595553",
      "title": "Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Clostridioides Difficile Infection",
      "start_date": "2019-01-28",
      "completion_date": "2021-11-17",
      "enrollment": 0,
      "sponsor": "Summit Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 48,
    "by_phase": {
      "PHASE2": 21,
      "PHASE3": 8,
      "NA": 7,
      "EARLY_PHASE1": 2,
      "PHASE4": 2,
      "PHASE1": 2,
      "": 5,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 4,
      "RECRUITING": 18,
      "COMPLETED": 15,
      "NOT_YET_RECRUITING": 5,
      "TERMINATED": 3,
      "UNKNOWN": 3
    },
    "active_trials": 22,
    "completed_trials": 15,
    "conditions": [
      "Advanced Head and Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma, Stage III Head and Neck Cutaneous Squamous Cell Carcinoma, Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma",
      "Amputation, Phantom Limb, Stump Pain",
      "Biliary Tract Cancer",
      "Cancer",
      "Clostridioides Difficile Infection",
      "Clostridium Difficile Infection",
      "Covid-19, Subjects Vaccinated Against Covid-19",
      "Cutaneous Squamous Cell Carcinoma",
      "Duchenne Muscular Dystrophy",
      "Endometrial Cancer, Cervical Cancer",
      "Extensive Stage Lung Small Cell Cancer",
      "Fatigue",
      "Genitourinary Abnormality, Breast Cancer Female, Vaginal Abnormality, Urinary Tract Infections, Dyspareunia, Dysuria",
      "Glioblastoma",
      "Harm Reduction, Naloxone, Opioid Overdose",
      "Heart Disease",
      "Ivonescimab, Clear Cell Renal Carcinoma",
      "MRI",
      "Metastatic Colorectal Cancer",
      "Metastatic Colorectal Cancer (CRC)",
      "Metastatic Esophageal Adenocarcinoma, Advanced Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma, Advanced Gastric Adenocarcinoma",
      "Multiple Sclerosis",
      "Muscular Dystrophy, Duchenne",
      "Non Small Cell Lung Cancer",
      "Non-Small Cell Lung Cancer",
      "Non-Squamous Non-small Cell Lung Cancer",
      "Nutrition Education, Enhanced Recovery After Surgery",
      "Open-Angle Glaucoma, Ocular Hypertension",
      "Peripheral Arterial Disease",
      "Pleural Mesotheliomas",
      "Postoperative Pain Following Knee Arthroplasty",
      "Pregnancy, Neonatal Mortality, Tuberculosis, Hepatitis B, Hypertension, Diabetes Mellitus",
      "Respiratory Distress Syndrome, Bronchopulmonary Dysplasia",
      "Salivary Gland Cancer, Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Cancer, Adenoid Cystic Carcinoma",
      "Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)",
      "Stomach Cancer Stage IV, Esophagus Cancer, Stomach Cancer",
      "TBI Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Post Concussive Syndrome",
      "TNBC, TNBC - Triple-Negative Breast Cancer, Early Stage Triple-Negative Breast Carcinoma",
      "Thymus Carcinoma",
      "Urolithiasis, Kidney Stone, Kidney Stones"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:57.444952",
    "search_query": "Summit Therapeutics Inc.",
    "url": "https://clinicaltrials.gov/search?term=Summit+Therapeutics+Inc."
  }
}